Clinical Trials Directory

Trials / Completed

CompletedNCT05700747

Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
MGH Institute of Health Professions · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities. The name of the study intervention involved in this study is: Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)

Detailed description

The goal of this single arm, pilot study of the Health Through Activity (HTA) rehabilitation intervention for people living with multiple myeloma is to determine if investigators can feasibly deliver the program out of the IMPACT Practice Center at the MGH Institute for Health Professions. \- The six-session 'Health Through Activity' program provides a customized exercise plan and encourages engagement in activities to reduce disability and improve quality of life. * Study procedures including screening for eligibility, in-clinic visits, questionnaires, and surveys. * Participation in this research study is expected to last up to 4 months. It is expected that up to 20 people will take part in this research study. An internal grant from the Massachusetts General Hospital Institute of Health Professions is providing equipment and staffing for this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHealth Through ActivitySix, weekly, customized sessions with licensed physical and occupational therapists.

Timeline

Start date
2023-02-01
Primary completion
2025-03-28
Completion
2025-03-28
First posted
2023-01-26
Last updated
2025-12-16
Results posted
2025-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05700747. Inclusion in this directory is not an endorsement.